U.S. Markets open in 31 hrs, 29 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 2.12 09:30 AM EST | |
|---|---|---|
| Day High | 2.29 03:59 PM EST |
|
| Range | 0.17 |
| Volume | 258,399 | |
|---|---|---|
| 30-Day Avg Vol | 129,000 |
|
| Difference | 100.31% |
| Market Cap | 88.99 M | |
|---|---|---|
| Mkt Cap Chg | 4.70 M |
| Shares Out | 39.20 M | |
|---|---|---|
| % Shrs Traded | 0.66% | |
| 1yr EPS Est | -1.064 |
| 52-Wk Low | 2.00 | |
|---|---|---|
| 52-Wk High | 4.41 |
|
| Range | 2.41 |
| Prev Close | 2.15 11/5/09 | |
|---|---|---|
| Today's Open | 2.12 | |
| Change | -1.40% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 1.41 M |
| Revenue (LFY) | 3.97 M | |
|---|---|---|
| Earnings (LFY) | -88.61 M | |
| Earnings (MRQ) | -8.18 M | |
| Next Earn Est | -0.284 | |
| Next Earnings | 02/03/2010 |
|
| EPS (TTM) | -1.86 | |
| 1yr EPS Growth | 42.80% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -2.00 | |
| PEG Ratio | — | |
| Return on Equity | -113.47 | |
| Beta | 0.65 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
For Neurocrine Biosciences, biology is all chemistry. The development-stage biotech develops treatments for neurological and endocrine-related diseases, such as insomnia, depression, and pain. Lead drug ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.284 2/3/10 | — — |
—
—
|
| Last Quarter | -0.352 9/30/09 | -0.21 9/30/09 |
0.142
Beat
|
| 2 Quarters Ago | -0.40 6/30/09 | -0.39 6/30/09 |
0.01
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 733,000.00 | 3.98 M |
| Gross Profit | -26,000.00 | -3.64 M |
| Operating Income | -9.63 M | -69.46 M |
| Net Income | -8.18 M | -88.61 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts